Language selection

Search

Patent 2004125 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2004125
(54) English Title: PHOSPHONATE REAGENT COMPOSITIONS AND METHODS OF MAKING SAME
(54) French Title: REACTIF DE PHOSPHONATE ET METHODE DE PRODUCTION
Status: Dead
Bibliographic Data
(52) Canadian Patent Classification (CPC):
  • 260/395
(51) International Patent Classification (IPC):
  • C07F 9/40 (2006.01)
  • C07C 403/20 (2006.01)
  • C07C 403/24 (2006.01)
(72) Inventors :
  • BABLER, JAMES H. (United States of America)
(73) Owners :
  • LOYOLA UNIVERSITY OF CHICAGO (United States of America)
(71) Applicants :
  • BABLER, JAMES H. (United States of America)
(74) Agent: GOWLING LAFLEUR HENDERSON LLP
(74) Associate agent:
(45) Issued:
(22) Filed Date: 1989-11-29
(41) Open to Public Inspection: 1991-05-29
Examination requested: 1996-10-15
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data: None

Abstracts

English Abstract





ABSTRACT

Novel phosphonate compounds of the formula


Image



are disclosed and claimed, as well as methods for
manufacturing the phosphonates from C-14 through C-16
aldehydes. The phosphonate compounds of the present
invention can be employed to form 13-cis-retinoic acid,
retin-A and beta-carotene.


Claims

Note: Claims are shown in the official language in which they were submitted.



- 24 -
WHAT IS CLAIMED IS:

1. Phosphonates of the formula:


Image



in which R is an alkyl group having up to
four carbon atoms, and R1 is a 3-methyl pentadienyl
group.

2. The phosphonate of Claim 1 wherein R1 is
selected from the group consisting of


Image



Image, and


Image


3. The phosphonate of Claim 1 which is 3-
methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4
pentadienylphosphonic acid, diethyl ester.


- 25 -

4. The phosphonate of Claim 1 which is 3-
methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4-
pentadienylphosphonic acid, diisopropyl ester.

5. The phosphonate of Claim 1 which is 3-
methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-
pentadienylphosphonic acid, diethyl ester.

6. The phosphonate of Claim 1 which is 3-
methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-
pentadienylphosphonic acid, diisopropyl ester.

7. The phosphonate of Claim 1 which is 3-
methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,4-
pentadienylphosphonic acid, diethyl ester.

8. The phosphonate of Claim 1 which is 3-
methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,4-
pentadienylphosphonic acid, diisopropyl ester.

9. A process for forming a phosphonate ester
comprising:
A) forming a reaction mixture in an organic
solvent of
(i) an aldehyde having the structure:



Image


- 26 -

wherein R2 is

Image Image,
or and R3 is methyl,
ethyl or propyl;
(ii) a methylene-bis-phosphonic acid
ester of the formula:


Image


wherein each R, which can be the same
or different, is selected from the group
consisting of alkyl groups having up to four
carbon atoms; and,
(iii) at least one equivalent of a base;
and
B) isolating said phosphonate ester from said
reaction mixture.

10. The process of Claim 9 wherein said
aldehyde is selected from the group consisting of:


and
Image

Image


11. The process of Claim 10 wherein said
methylene-bis-phosphonic acid ester is
methylenebisphosphonic acid, tetraisopropyl ester.


- 27 -

12. The process of Claim 10 wherein said
methylene-bis-phosphonic acid ester is
methylenebisphosphonic acid, tetraethyl ester.

13. The process of Claim 9 wherein said
aldehyde is 2-methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-
yl)-3-butenal.

14. The process of Claim 9 wherein said base
is selected from the group consisting of: sodium
hydride; alkoxides of Group I metals; and, alkali metal
carbonates.

15. A process for forming a 3-methyl-5-
(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4-
pentadienylphosphonic acid, dialkyl ester, comprising
the following steps:
A) forming a first reaction mixture in an
organic solvent of
(i) a C-14 aldehyde selected from the
group consisting of


Image

and


Image


- 28 -

(ii) a methylene-bis-phosphonic acid
ester of the formula:


Image
; and

(iii) at least one equivalent of a base;
B) separating a pentadienylphosphonic acid,
dialkyl ester intermediate from said first reaction
mixture;
C) forming a second reaction mixture
comprising:
(i) the dialkyl ester intermediate of
step B,
(ii) an organic solvent, and
(iii) a basic catalyst; and
D) isolating 3-methyl-5-(2,6,6-trimethyl-1-
cyclohexen-1-yl)2,4-pentadienylphosphonic acid, dialkyl
ester from said second reaction mixture.

16. The process of Claim 15 wherein said
methylenebisphosphonic acid ester is selected from the
group consisting of methylenebisphosphonic acid,
tetraethyl ester and methylenebisphosphonic acid, tetra-
isopropyl ester.

17. The process of Claim 15 wherein said base
employed in step A is selected from the group consisting
of: sodium hydride; alkoxides of Group I metals; and,
alkali metal carbonates.


- 29 -


18. The process of Claim 15 wherein said
basic catalyst employed in isomerization step C
comprises an alkoxide of a Group I metal.

19. The process of Claim 18 wherein said
Group I metal alkoxide is selected from the group
consisting of KOC(CH3)3, NaOCH3 or NaOCH2CH3.

20. The process of Claim 15 wherein said
organic solvent utilized in isomerization step C
comprises dimethyl sulfoxide.

21. A process for forming beta-carotene
comprising:
A) forming a reaction mixture in an organic
solvent of
(i) a 3-methyl-5-(2,6,6-trimethyl-1-
cyclohexen-l-yl)-2,4-pentadienylphosphonic
acid, dialkyl ester,
(ii) a base: and
(iii) 2,7-dimethyl-2,4-6-octatrienedial;
and
B) isolating beta-carotene from said reaction
mixture.

22. The process of Claim 21 wherein said
organic solvent comprises a mixture of tetrahydrofuran
and dimethyl sulfoxide.

23. The process of Claim 21 wherein said base
comprises an alkoxide of a Group I metal.


- 30 -

24. A process for forming an alkyl ester of
all-trans-retinoic acid comprising:
A) forming a reaction mixture in an organic
solvent of
(i) a 3-methyl-5-(2,6,6-trimethyl-1-
cyclohexen-1-yl)-2,4-pentadienylphosphonic
acid, dialkyl ester,
(ii) a base, and
(iii) an aldehyde of the formula


Image


where R is an alkyl group having up to four
carbons; and
B) isolating an alkyl ester of retinoic acid
from said reaction mixture.

25. The process of Claim 24 wherein said
aldehyde is selected from the group consisting of methyl
3-methyl-4-oxobutenoate and ethyl 3-methyl-4-
oxobutenoate.

26. The process of Claim 24 wherein said base
comprises an alkoxide of a Group I metal.

27. The process of Claim 24 wherein said
organic solvent comprises a mixture of tetrahydrofuran
and dimethyl sulfoxide.

- 31 -

28. A process for forming 13-cis-retinoic
acid comprising:
A) forming a reaction mixture in an organic
solvent of
(i) a 3-methyl-5-(2,6,6-trimethyl-1-
cyclohexen-1-yl)-2,4-pentadienylphosphonic
acid, dialkyl ester,
(ii) a base; and
(iii) 5-hydroxy-4-methyl-2-(SH) furanone;
and
B) isolating 13-cis-retinoic acid from said
reaction mixture.

29. The process of Claim 28 wherein said base
comprises an alkoxide of a Group I metal.

30. The process of Claim 28 wherein said
organic solvent comprises a mixture of tetrahydrofuran
and dimethyl sulfoxide.

Description

Note: Descriptions are shown in the official language in which they were submitted.


20n~s




BACRGROUND OF T~E INVENTION

The present invention relates to novel
phosphonates which can be employed as precursors to a
variety of biologically-active materials; including 13-
cis-retinoic acid (accutane), retin-A and beta
carotene. The phosphonates of the present invention can
be synthesized by the reaction of a cyclohexenyl-group-
containing C-14 through C-16 aldehyde, such as 2-methyl-
4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-butenal, with a
phosphonic acid ester, such as methylenebisphosphonic
acid, tetraethyl ester.
A procedure for producing vitamin A acetate
from beta-ionone has been described by Rei~ and Grassner
[Chemie-Inq.Techn., 45, 646-652 (1973)]:

OH
1 H ~ C ~ ~ HX
2 H2/cataly~t ~
r~ 1 , ~ ~ x ~
~ ~tr ph nyl -
o




~ 2 3 ~ 2 3 t--~ormyl-
~ crotyl ~c-tate

vitamin A ~c-t~t-

2n~4l2s



Similarly, Pommer and Kuhn [Angew.Chem., 72,
911 (1960)~ have described a procedure for preparing
beta-carotene from the same beta-ionone-derived
triphenylphosphonium salt:




~ ~ X ~

formed in the course of the ~eif, et al. synthesis. The
disadvantages of these procedures include the fact that
the triphenylphosphine reactant required for the
syntheses is relatively expensive and that the byproduct
of the reactions, Ph3PO, is not water soluble, thus
making it difficult to isolate the desired product.
Surmatis and Thommen have described a process
for preparing beta-carotene utilizing a phosphonate in a
Wittig-type reaction lJ.Org.Chem., 34, 559 (1969)]. An
essential step of this procedure invoi~es the reaction
of a C-20 dibromo compound with a trialkyl phosphite:

~ CH29r


o
~ c~c ~ cH2~lo~2
^~t-iyrt >

~ o ~ N-OCJ3, pyr~d~n-- >
~ ~, Ç~2Pl01l~2 2- ~X~Ho
r-eLnyL pbo~phon-t- ~
~-t~n~l


~t--e-rot-n-

Z004125



Although the C-20 dibromo compound of
Surmatis, et al. can be reacted with trialkyl
phosphites, the literature does not report similar
reactions for structurally related C-15 halides.
Indeed, the literature shows that the compound l-bromo-
3-methyl-5-(2~6~6-trimethyl-l-cyclohexen-l-yl)-2~4
pentadiene

~ CH2Br


is not stable at room temperature. (aull.Soc.Chim.Fr.,
15 Part II, 746-50 (1973)].
Other procedures for preparing retinoid
intermediates and beta-carotene are shown in the prior
art, e.g., Babler U.S. Patent 4,175,204; F. Frickel,
"The Retinoids", edited by M.B. Sporn, A.B. ~oberts and
D.S. Goodman, Academic Press (Orlando, Florida, 1984),
pp. 77-145; and R.S.H. Liu and A.E. Asato, Tetrahedron,
40, 1931-196g (1984).

SUMMARY OF THE INVENTION
The novel phosphonate compounds of the present
invention have the structural formula:


C~3 CH3
~ R1- P~OR)2
c~3





20n4l2~


in which R is an alkyl group having up to four carbon
atoms, and Rl is a 3-alkyl pentadienyl group wherein the
alkyl group at the 3 position is methyl, ethyl or
propyl. The two double bonds in the 3-alkyl pentadienyl
group, Rl, can be in the 1,3 or 2,4 positions
(conjugated) or in the 1,4 positions (non-conjugated).
The compounds of the present invention are
systematically named as esters of an alkenylphosphonic
acid~ Thus, for example, when Rl is:

CH3
I




-CH=CH-C=CH-CH2-


and R is ethyl, the compound is named 3-methyl-5-(2,6,6-
trimethyl-l-cyclohexen-l-yl)-2,4-pentadienylphosphonic
acid, diethyl ester. When Rl is:


-CH=CH-CH-CH=CH-


and R is isopropyl, the compound is named 3-methyl-5-
(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,4-
pentadienylphosphonic acid, diisopropyl ester.
Other compounds within the scope o~ the
present invention include:
3-methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-
pentadienylphosphonic acid, diethyl ester;
3-ethyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4-
pentadienylphosphonic acid, diethyl ester;

XO(~

-- 5

3-methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4-
pentadienylphosphonic acid, dimethyl ester;
3-methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4-
pentadienylphosphonic acid, dipropyl ester;
3-methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4-
pentadienylphosphonic acid, dibutyl ester;
3-propyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1,3-
pentadienylphosphonic acid, diethyl ester; and
3-methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4-
pentadienylphosphonic acid, diisopropyl ester.

Because of their ability to form known biologically-
active compounds, dialkyl esters of 3-methyl-5-(2,6,6-
trimethyl-l-cyclohexen-l-yl)-2,4-pentadienylphosphonic
acid, are especially preferred.
The compounds of thè present invention can be
formed by the base-promoted reaction of a C-14 through
C-16 aldehyde having the structure

CH3 CH3
~ R2CHO

CH3

IR3 IR3
wherein R2 is -CH=CH-CH- or -CH2-CH=C- and R3 is
methyl, ethyl or propyl, with a methylenebisphosphonic
acid ester having the structure:


O O
Il 11
(R0)2PcH2p(oR)2


2~)04125




wherein each R, which can be the same or different, is
selected from the class consisting of alkyl groups
having up to four carbon atoms. The preferred aldehydes
are C-14 materials which are derived from beta-ionone.
At room temperature, reaction of the aldehyde and
bisphosphonate ester proceeds rapidly (< 30 minutes) in
an organic solvent containir.g one equivalent of a base
(e.g., a Group I metal alkoxide or sodium hydr ~e):

o o

X~ Q2C~ = O + (RO) 2PCH2P(OR~ 2 + base or~anic solvent
r 1 ~ room temp .
15 ~

11
~<,~ Rl -- P(OR~ 2
11




`~' ~

wherein Rl is a 3~alkyl pentadienyl group, as defined
above, and R is a C-l to C-4 alkyl group. The
phosphonate ester product is soluble in a variety of
organic solvents and can be isolated from the reaction
mixture by convention~l techniques. Yields are
typically in excess of 90%.
A variety of organic solvents, both polar and
nonpolar, can be employed in the foregoing reaction,
3Q including hydrocarbons such as benzene, hexane,
cyclohexane, and toluene; ethers such as tetrahydrofuran
and diethyl ether; ethyl alcohol; polar solvents such as
dimethylformamide and dimethyl sulfoxide; or mixtures of
such organic solvents. Suitable bases include sodium
hydride, Group I metal alkoxides, and alkali metal
carbonates.

Z0041Z~



As noted previously, the double bonds in the
pentadienyl moiety can be in the 1,3-; 1,4- or 2,4-
positions. The 1,3- and 1,4- compounds can be
isomerized to the preferred 2,4- pentadienyl
phosphonates by employing a base catalyst such as an
alkoxide of a Group I metal, i.e., KOC(CH3)3, NaOCH3, or
NaOCH2CH3 with an organic solvent such as dimethyl
sulfoxide (DMSO).

10 ~CH = CHPIOR) 2 O

OR alk~xid~ ~ fX~. CH2P ~OR) 2
/ C~3 DMSo
X' CH2CH = C
~J~ ~ CH = CHP(OR) 2



In general, any orqanic solvent in which the
reactants are soluble may be employed in the practice of
the above two steps ~i.e., preparation of the
phosphonate ester and its subsequent isomerization).
Any base whose conjuqate acid has a PKa of approximately
8 or above can be utilized to promote these reactions.
The aldehyde reactant ~e.q., 2-methyl-4-
(2',6',6'-tri-methyl-1'-cyclohexen-1'-yl)-3-~utenal]
used to synthesize the phosphonate esters can be
prepared in accordance with known procedures. Processes
for synthesi2ing such aldehydes from ~eta-ionone are
shown, for example, in O. Isler, et al.,
Helv.Chim.Acta., 30, 1911 (1947); V. Ramamurthy, et al.,
Tetrahedron, 31, 193 (1975), or M~ ~osenberqer, et al.,
Helv.Chim.Acta, 63, 1665 (1980).

20~ 2~



The methylenebisphosphonic acid ester reactant
can be prepared by reacting methylene bromide with a
trialkyl phosphite [P(OR)3] in accordance with the
procedure shown in B. Costisella, J. fur prakt. Chemie,
324, 537 (1982), e.g.,


2Br2 + 2 P[OCH(C~ ) ] heat

O O
Il 11
[(CH3)2CHO]2 PCH2P[OCH(CH3)2]2

methylenebisphosphonic acid, tetraisopropyl ester, 73
yield.
The compounds of the present invention can be
used in the synthesis of retinoids or beta-carotene.
Illustrative examples of three such syntheses employing
the novel phosphonate compounds are as follows:





~0~)4125



SYnthesis of all-trans-retinoic acid (retin-A~



CH3 O O organic solvent,
~ CHCH = O ~(cH3cH2o)2pcH2p~ocH2cH3)2 2base >

2-methyl-4-l2',6',6'-methyieneb~ho~phonic
trim-thyl-l'-cyclo-acld/tetraet yl eJter
hexen-l '-yl)-3-butenal


CH3 o
~ CHCH = CHp(ocH2cH3)2 ba-e ~c g , KoclcH3)~ ~r


~ 90~ yield


Il
~ CH2P~OCH2CH3)2 CH3 C / COOCH3 ~OC(CH3)3

~ CH3 CH ~ \ H

~solc product)


COCH3

methyl e~t-r of reeinoic acit

200~1~5


-- 10 --

Synthesis of 13-cis-retinoic acid ~accutane)


o
CH2P~OCH2CH3)2 CH3
+ 2 equiv. KOC(CH3)3 + OH ~ ~O

5-hydroxy-4-methyl
2-(5H) furanone

THF/DMSO ~ ~
COOH

13~cls-retinoic acid



SYnthesis of beta-carotene
o

2 equiv ~ ~ CH2P~OCH2CH3)2 + 2 equlv KOC(CH3)3 +
o
H\ / CH = ~/
CH3 C 2 C CH3
/ ~ THF/DMSO ~
~C = CH H 20-C ~'
o
2,7-di~ethyl-2,4,6-octatrie~edial


~ ~ ~ _

3-c~roten- 1>60- yield)

20n4~25




DETAILED DESCRIPTION OF THE INVENTION
The following examples illustrate in greater
detail the practice of the present invention,
S specifically: (i) the preparation of intermediates which
can be utilized to form the phosphonate compounds of the
present invention (Examples I-V); (ii) the preparation
of representative novel phosphonate compounds (Examples
VI-XI); (iii) the preparation of intermediates which can
be reacted with the compounds of the present invention
to form biologically-active materials (Examples XII-
XIV); and, (iv) the preparation of biologically-active
compounds utilizing the novel phosphonate compounds of
the invention (Examples XV-XVII).
EXAMPLE I
Preparation of Methylenebisphosphonic
Acid, TetraethY1 Ester
In accordance with a procedure suggested by
H. Gross, et al., Journal fur prakt. Chemie, 324, 537
(1982~, a mixture of 4.00 ml (57.0 mmoles) of
dibromomethane and 30 mL (175 mmoles) of triethyl
phosphite was gradually warmed to 90C over a period of
15 minutes. After maintaining the temperature at 90C
for an additional 10 minutes, the solution ~as warmed to
140C and kept at that temperature for 2 hours. At that
point, the mixture was warmed to 160C ~external bath
temperature) and heated at that temperature for an addi-
tional 15 hours, during which time ethyl bromide was
slowly distilled out of the reaction mixture. Next,
excess triethyl phosphite was distilled from the
reaction flask, followed by distillative removal of
minor amounts of ethylphosphonic acid, diethyl ester.
The desired product was then obtained by distillation
under reduced pressure, affording 9.03g (55% yield) of

2(~4125

- 12 -

bisphosphonate: bp 145-160C (bath temperature, 0.25
mm). H. Gross, et. al., reported a 70% yield of the
same compound, prepared on a larger scale (150 mmoles of
dibromomethane).




EXAMPLE II
Preparation of Methylenebisphosphonic
Acid, Tetraisopropyl Ester
A mixture of 1.00 ml (14.25 mmoles) of
dibromomethane and 11.0 mL (44.5 mmoles) of triisopropyl
phosphite was heated in the same manner as described in
the procedure of Example I. Removal of excess
triisopropyl phosphite, followed by a minor amount of
isopropylphosphonic acid, diisopropyl ester, by
distillation at reduced pressure, and subsequent
evaporative distillation [bath temperature: 138-152C
(0.25 mm)] afforded 3.57 g (73% yieid) of the desired
bisphosphonate.

EXAMPLE III
Preparation of 2-Methyl-2-[2-l2,6,6-
trimethYl-l-cvclohexen-l-yl)ethenYlloxirane
A mixture of 762 mg (19.1 mmoles) of sodium
hydride (60% dispersion in mineral oil, which was
removed ~y washing with hexane prior to the addition of
DMSO) and 6.0 m~ of anhydrous dimethyl sulfoxide (DMSO)
was heated, protected from atmospheric moisture, at a
bath temperature of 65C for approximately 45 minutes --
until evolution of hydrogen had ceased. After cooling
this mixture to room temperature, it was added dropwise
over a period of 10 minutes to a stirred slurry of
3.9549 (19.38 mmoles) of trimethylsulfonium iodide in
12.0 mL of 1:1 ~v/v) anhydrous DMSO: tetrahydrofuran,
protected from atmospheric moisture and kept cold in an
ice-brine bath at approximately -5C. The resulting

2()~)412~



gray suspension was stirred for an additional 5 minutes,
after which a solution of 1.42g (7.38 mmoles) of beta-
ionone in 3.00 mL of anhydrous tetrahydrofuran was added
dropwise rapidly. This mixture was subsequently stirred
at approximately O~C for 2 hours, after which it was
allowed to warm to room temperature. The product was
isolated, after addition of 1 mL of water to quench the
reaction, by dilution of the mixture with 50 mL of
pentane and 100 mL of 10% aqueous sodium chloride.
Separation of the layers was followed by washing the
organic layer with 10% aqueous sodium chloride (2 x 100
mL), water (1 x 100 mL), and saturated brine
(1 x 100 mL) in successive order. The organic extracts
were then dried over anhydrous sodium sulfate and
subsequently filtered. Removal of the pentane and
tetrahydrofuran by evaporation at reduced pressure
afforded 1.52 g (100~ yield) of the desired epoxide.

EXAMPLE IV
Preparation of 2-Methyl-4-~2,6,6-
trimethyl-l-cyclohexen-l-yl)-3-butenal
~ solution of 1.502 9 (7.28 mmoles) of the
epoxide, prepared as described in Example III, in 6.00
mL of anhydrous ether was added dropwise over 5 minutes
to a stirred suspension of magnesium bromide [prepared
_ situ from 355 mg (1.88 mmoles) of 1,2-dibromoethane
and 48 mg (1.98 milli-g-atoms) of magnesium turnings] in
3.00 mL of anhydrous ether, protected from atmospheric
moisture, at -10C. The resulting mixture was stirred
at -10C for an additional 5 minutes, after which it was
diluted with 20 mL of solvent ether~ The organic layer
was washed in successive order with 15 mL portions of
water and saturated brine, after which it was dried over
anhydrous sodium sulfate and subsequently filtered.
Removal of the ether by evaporation at reduced pressure

20(~1XS


- 14 -

afforded 1.40 g (93% yield) of the desired aldehyde,
whose structure was verified by NMR analysis [~ 9.69,
doublet, J = 1.8 Hz, CHO; ~ 1.25, doublet, J = 7 Hz,
CHCH3]. The procedure used in Examples III a~d IV was
developed by M. Rosenberger, et al. [Helv. Chim. Acta.,
_ , 1665 (1980)]. An alternate route to this same
aldehyde can be found in O. Isler, et al., Helv. Chim.
Acta., 30, 1911 (1947), subsequently modified by R.S.H.
Liu, et al., Tetrahedron, 31, 193 (1975).
EXAMPLE V
Preparation of 2-Methyl-4-(2,6,6-
trimethyl-l-cYclohexen-l-yl)-2-butenal
A mixture of 920 mg (4.46 mmoles) of the
aldehyde prepared as described in Example IV and 45 mg
of potassium hydroxide pellets in 3.0 mL of methyl
alcohol containing 0.05 mL of water ;~as stirred,
protected from atmospheric moisture, at 20C for 35
minutes. The product was isolated after dilution of the
mixture with 30mL of 1:1 (v/v) pentane: ether and
subsequent washing of the organic layer with 25 mL
portions of 10% aqueous sodium chloride and saturated
brine. Drying of the organic extracts over anhydrous
magnesium sulfate, followed by filtration and removal of
the pentane and ether at reduced pressure, afforded 916
mg (99.6% yield) of the isomerized aldehyde, whose
structural identity was confirmed by NMR analysis
(~ 9.45, singlet, CHO~.

EXAMPLE VI
Preparation of 3-Methyl-5-(2,6,6-
trimethyl-l-cyclohexen-l-yl)-1,3-
~ntadienylphosphonic acid, Diethyl E~ter
A solution of 508 mg (1.76 mmoles) of
methylenebisphosphonic acid, tetraethyl ester, prepared

Z0~12~



as described in Example I, in 2.5 mL of benzene and 1.5
mL of anhydrous tetrahydrofuran (THF) was added dropwise
slowly over 5 minutes to a stirred mixture of 69 mg (1.7
mmoles) of sodium hydride (60~ dispersion in mineral
oil, which was removed prior to the reaction by washing
with hexane) and 1.0 mL of benzene, protected from
atmospheric moisture and maintained at a temperature o~
15-20C by use of an external cold water bath. This
mixture was stirred for an additional 15 minutes, after
which a solution of 20~ mg (1.01 mmole) of aldehyde
(prepared as described in Example V) in 2.5 mL of
benzene was added dropwise rapidly. After stirring this
mixture at room temperature for 25 minutes, it was
diluted with 20 mL of 1:1 ~v/v) pentane: ether and
washed in successive order with 7:3 (v/v) lM aqueous
sodium hydroxide: methyl alcohol (2 x 40 mL) to remove
excess bisphosphonate and then with saturated brine (20
mL). The organic layer was then dried over anhydrous
magnesium sulfate and subsequently filtered. Removal of
the pentane, ether, and benzene by evaporation at
reduced pressure afforded 320 mg (93~ yield) of the
desired vinyl phosphonate.

EXAMPLE VII
Preparation of 3-Methyl-5-(2,6,6-
trimethyl-l-cyclohexen-l-yl)-1,3-
pentadienylphosphonic Acid, Diisopropyl Ester
The ylide was prepared in the manner described
in the procedure of Example VI by reaction of 605 mg
(1.76 mmoles) of methylenebisphosphonic acid,
tetraisopropyl ester (produced in accordance with
Example II), with 69 mg (1.7 mmoles) of 60~ sodium
hydride. Subsequent addition of 195 mg (0.95 mmole) of
the unsaturated aldehyde produced in accordance with
Example V and stirring of the mixture at 20C for 25

ZO(~4125


- 16 -

minutes completed the reaction. The product was
isolated after dilution of the mixture with 20 mL of 1:1
(v/v) pentane: ether and washing in successive order
with 1:1 (v/v) lM aqueous sodium hydroxide: methyl
S alcohol (2 x 40 mL) to remove excess bisphosphonate and
then with saturated brine (20 mL). The organic layer
was then dried over anhydrous magnesium sulfate and
subsequently filtered. Removal of the pentane, ether,
and benzene by evaporation at reduced pressure afforded
313 mg (90% yield) of the desired vinyl phosphonate.

EXAMPLE VIII
Preparation of 3-Methyl-5-(2,6,6-
trimethyl-l-cyclohexen-l-yl~-1,4-
pentadienylphosphonic Acid, DiethYl Ester
The reaction was conducted in the mannerdescribed in the procedure of Example VI using the
following reagents: 2.96 g (10.25 mmoles) of
methylenebisphosphonic acid, tetraethyl ester (produced
in accordance with Example I), in 20 mL of 3:2 (v/v)
benzene: anhydrous tetrahydrofuran; 413 mg (10.3 mmoles)
of 60% sodium hydride in 8.0 mL of benzene; and 1.204 g
(5.85 mmoles) of unsaturated aldehyde (produced in
accordance with Example IV) in 12.0 mL of benzene.
Isolation of the product as described in the procedure
of Example VI afforded 1.901 g (95.5% yield) of the
desired vinyl phosphonate.

EXAMPLE IX
Preparation of 3-Methyl-5-(2,6,6-
trimethyl-l-cyclohexen-l-yl)-1,4-
pentadienYlphosphonic Acid, DiisoPropyl Ester
The reaction was conducted in the manner
described in the procedure of Example VII using the
following reagents: 303 mg (0.88 mmole) of

X0~4~2~j



methylenebisphosphonic acid, tetraisopropyl ester
(produced in accordance with Example II), in 2.5 mL of
3:2 (v/v~ benzene: anhydrous tetrahydrofuran; 36 mg
(0.90 mmole) of 60% sodium hydride in 1.0 mL of benzene;
and 98 mg (0.47 mmole) of unsaturated aldehyde (produced
in accordance with Example IV) in 1.5 mL of benzene.
Isolation of the product as described in the procedure
of Example VII afforded 104 mg (60% yield) of the
desired vinyl phosphonate.
EXAMPLE X
Preparation of 3-Methyl-5-(2,6,6-
trimethyl-l-cyclohexen-l-yl)-2,4-
pentadienylPhosphonic Acid, Diethyl E ter
A mixture of the vinyl phosphonate produced in
accordance with Example VIII (943 mg, 2.77 mmoles) and
99 mg (0.88 mmoles) of potassium tert-butoxide in 12 mL
of anhydrous dimethyl sulfoxide (DMSO) was stirred,
protected from atmospheric moisture, at 20C for 80
minutes. The prGduct was isolated by dilution of the
reaction mixture with 100 mL of ether and subsequent
washing with 120 mL portions of 10% aqueous sodium
chloride (4 x 120 mL). The organic layer was then dried
over anhydrous magnesium sulfate and filtered. Removal
of the e~her by evaporation at reduced pressure afforded
718 mg (76% yield) of the desired allylic phosphonate,
whose structural integrity was confirmed by NMR analysis
[~ 2.75, doublet of doublets, J = 8 Hz and 22 Hz,
CH2P]. In a similar manner, this allylic phosphonate
could be prepared by isomerization of 3-methyl-5-~2,6,6-
trimethyl-l-cyclohexen-l-yl)-1,3-pentadienylphosphonic
a~id, diethyl ester, produced in accordance with Example
VI.


;~O~lZ5


- 18 -

EXAMPLE XI
Preparation of 3-Methyl-5-(2,6,6-
trimethyl-l-cyclohexen-l-yl)-2,4-
p~n~adienylphosphonic Acid, Diisopropyl Ester
A mixture of vinyl phosphonate produced in
accordance with Example VII (308 mg, 0.84 mmole) and 88
mg. (0.78 mmole) of potassium tert-butoxide in 4 mL of
anhydrous dimethyl sulfoxide was stirred, protected from
atmospheric moisture, at 20C for 30 minutes. Isolation
of the product in the manner described in the procedure
of Example X afforded 238 mg (77% yield) of the desired
allylic phosphonate. This latter compound could also be
prepared by isomerization of 3-methyl-5-(2,6,6-
trimethyl-l-cyclohexen-l-yl)-1,4-pentadienylphosphonic
acid, diisopropyl ester, produced in accordance with
Example IX.

EXAMPLE XII
Preparation of 2-Butenyl-1,4-
bi~phosphonic Acid, Tetraethvl Ester
A solution of 2.00 mL (18.9 mmoles) of trans-
1,4-dichloro-2-butene in 3.00 mL (17.5 mmoles) of
triethyl phosphite was added dropwise slowly over 25
minutes to a flask containing 5.00 mL (29.2 r~moles) of
triethyl phosphite, maintained at a temperature of
approximately 140C (external oil bath temperature).
This mixture was subsequently heated at 140C for an
additional 12 hours, during which time ethyl chloride
was continuously distilled out of the reaction flask.
At that point, the external oil bath temperature was
raised to 180C to distill over as much of the remaining
triethyl phosphite as possible. The desired product was
then obtained by fractional distillation under reduced
pressure, affording 5.40 9 (87.5% yield) of bis-
phosphonate: bp 161-184C ~bath temperature, 0.25 mm).

ZO~


-- 19 --

EXAMPLE XIII
Preparation of 1,1,8,8-
Tetramethoxy-2,7-dimethyl-2,4,6-octatriene
To a solution of 312 mg (0.95 mmole) of 2-
butenyl-1,4-bisphosphonic acid, tetraethyl ester
(produced in accordance with Example XII), and 0.25 mL
(2.07 mmoles) of pyruvic aldehyde dimethyl acetal
(available from Aldrich Chemical Co.) in 3.25 mL of 12:1
(v/v) anhydrous tetrahydrofuran: dimethyl sulfoxide,
protected from atmospheric moisture and maintained at a
temperature of approximately 5C by use of an external
ice water bath, was added 211 mg (1.88 mmoles) of
potassium tert-butoxide. This mixture was subsequently
stirred in the cold for 15 minutes and then at room
temperature for 7 hours. The product was isolated by
dilution of the mixture with 30 mL of 1:1 (v/v) ether:
pentane and subsequent washing of the organic layer with
10% aqueous sodium chloride (3 x 30 ml). The organic
layer was then dried over anhydrous sodium sulfate and
filtered. Removal of the volatile organic solvents by
evaporation at reduced pressure afforded 151 mq (62
yield) of bisacetal.

EXAMPLE XIV
Preparation of 2,7-Dimethvl-2,4,6-octatrienedial
A solution of 150 mg (0.585 mmole) of 1,1,8,8-
tetramethoxy-2,7-dimethyl-2,4,6-octatriene, produced in
accordance with Example XIII, in 3.5 mL of 4:2:1 (v/v/v)
glacial acetic acid: tetrahydrofuran: water was heated
at 45~C ~external oil bath temperature) for 3 hours.
After cooling the solution to room temperature, the
product was isolated by dilution of the mixture with 25
mL of 4:1 (v/v) ether: dichloromethane and washing the
organic layer in successive order with saturated brine

2()~)412~ri


- 20 -

(2 x 25 mL), 4:1 (v/v) saturated brine: lM aqueous
sodium hydroxide (2 x 25 mL), and saturated brine (~5
mL). The organic layer was then dried over anhydrous
magnesium sulfate and filtered. Removal of the volatile
organic solvents by evaporation at reduced pressure
afforded 86 mg (90% yield) of the desired bisaldehyde,
previously prepared in a similar manner by H. Pommer,
et al., Anqew. Chem., 72, 911 (1960).

EXAMPLE XV
Preparation of Beta-Carotene
To a solution of 192 mg (0.564 mmole) of 3-
methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4-
pentadienylphosphonic acid, diethyl ester (produced in
accordance with Example X) and 41 mg (0.25 mmole) of
2,7-dimethyl-2,4,6-octatrienedial (produced in
accordance with Example XIV) in 2.25 mL of 8:1 (v/v)
anhydrous tetrahydrofuran: dimethyl sulfoxide, protected
from atmospheric moisture and maintained at a
temperature of approximately 5C by use of an external
ice water bath, was added 59 mg ~0.526 mmole) of
potassium tert-butoxide. This mixture was subsequently
stirred in the cold for 15 minutes and then at room
temperature for 3~5 hours. The product was isolated by
dilution of the mixture with 25 mL of 4:1 (v/v) ether:
dichloromethane and subsequent washinq of the organic
layer with 25 mL portions of 10% aqueous sodium chloride
(3 x 25 mL). The organic layer was then dried over
anhydrous magnesium sulfate and filtered. Removal of
the volatile organic solvents by evaporation at reduced
pressure, followed by filtration through a small column
of silica gel (10 mL, 60-200 mesh, elution with 40 mL of
3:1 (v/vj hexane: benzene~ to remove any unreacted
starting materlals afforded 82 mg (61% yield) of deep-
purple crystals, identifi~d by NMR analysis as beta-
carotene: mp 183-185C.

lZ.~


- 21 -

EXAMPLE XVI
Preparation of all-trans Retinoic Acid, Ethyl Ester
.




To a solution of 57 mg (0.40 mmole) of ethyl
3-methyl-4-oxobutenoate (prepared according to a
procedure described by R.W. Curley, Jr.v et al.,
J.Org.Chem., 51, 256 (1986); an alternate synthesis has
been described by A. Guingant, et al., J.Org.Chem., 52,
4788 (1987); the compound is commercially available from
Fluka Chemical Corp., Ron Kon Koma, New York 11779.] and
132 mg (0.388 mmole) of 3-methyl-5-(2,6,6-trimethyl~l-
cyclohexen-l-yl)-2,4-pentadienylphosphonic acid diethyl
ester (produced in accordance with Example X) in 3.5 mL
of 6:1 (v/v) anhydrous tetrahydrofuran: dimethyl
sulfoxide, protected from atmospheric moisture and
maintained at a temperature of approximately 5C by use
of an ice water bath, was added 43 mg (O.38 mmole) of
potassium tert-butoxide. This mixture was subsequently
stirred in the cold for 10 minutes and then at room
temperature for 6 hours. The product was isolated by
dilution of the mixture with 30 mL of 1:1 (v/v) pentane:
ether and subseqùent washing of the organic layer with
30 mL portions of 10% aqueous sodium chloride (3 x 30
mL). The organic layer was then dried over anhydrous
magnesium sulfate and filtered. Removal of the volatile
organic solvents by evaporation at reduced pressure,
followed by filtration through a small column of silica
gel (15 mL, 60-200 mesh, elution with 75 mL of hexane -
4~ ether) to remove any unreacted starting materials,
afforded 76 mg (61% yield) of ethyl retinoate shown by
high-field (300 MHz) NMR analysis to be predominantly
the all trans stereoisomer. The product was
characteri~ed by three broad singlets of equal intensity
at 6 2.37, 2.02, and 1.73 (3 vinyl methyls). For tables
listing spectroscopic properties of retinoids, see:

412S



R.S.H. Liu, et al. Tetrahedron, 40, 1931-1969 (1984).
Ethyl retinoate was also prepared in a similar manner
from ethyl 3-methyl-4-oxobutenoate and 3-methyl-5-
(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4-
pentadienylphosphonic acid diisopropyl ester (producedin accordance with Example XI).

EXAMPLE XVII
Preparation of 13-cis-Retinoic Acid
To a solution of 88 mg (0.258 mmole) of 3-
methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4-
pentadienylphosphonic acid diethyl ester (produced in
accordance with Example X) and 37 mg (0.324 mmole) of 5-
hydroxy-4-methyl-2-(SH) furanone [prepared according to
a procedure described by G. Pattenden, et al.,
J.Chem.Soc.(C), 1984 (1968). An alternate synthesis has
been described by C.G. Wermuth, et al., J.Org.Chem., 46,
4889 (1981).] in 2.25 mL of 8:1 (v/v) anhydrous
tetrahydrofuran: dimethyl sulfoxide, protected from
atmospheric moisture and maintained at a temperature of
approximately 5C by use of an ice water bath, was added
64 mg (0.57 mmole) of potassium tert-butoxide. This
mixture was subsequently stirred in the cold for 15
minutes and then at room temperature for 3.5 hours.
After aci'difying the mixture by addition of 0.50 mL of
2M aqueous hydrochloric acid, it was diluted wi~h 25 mL
of 4:1 (v/v) ether: dichloromethane. The organic layer
was washed in successive order with 10% aqueous sodium
chloride (2 x 25 mL), water (1 x 25 mL), and saturated
brine (1 x 25 mL), dried over anhydrous magnesium
sulfate, and filtered. Removal of the volatile organic
solvents by evaporation at reduced pressure, followed by
filtration throu~h a small column of silica gel (6 mL,
40-140 mesh, elution with 25 mL of pentane - 20% ether~
to remove any unreacted phosphonate afforded 44 mg (57

~o~

- 23 -

yield) of orange crystals, shown by NMR analysis (in
CDC13 solution) to be a mixture of stereoisomers. The
predominate stereoisomer (comprising approximately 75-
80% of the mixture) was characterized by a doublet (J =
15 Hz) at ~ 7.81 (vinyl hydrogen bonded to C-12), a
broad singlet at ~ 5.~8 (vinyl hydrogen bonded to C-14),
and a broad singlet at ~ 2.11 (CH3 bonded to C-13). By
comparison with the NMR data reported (in "tau values",
where "tau" = 10 -~) for various stereoisomers of
retinoic acid by Pattenden, et al., [J.Chem.Soc.,C.,
1984-1997 (1968)], this major component was shown to be
13-cis-retinoic acid. The other (minor) component in
the product exhibited broad singlets at ~ 5.82 (vinyl
hydrogen bonded to C-14) and ~ 2.37 (CH3 bonded to C-
13), absorptions characteristic of all-trans retinoic
acid.
Although the foregoing invention has been
described in some detail by way of example, various
changes and modifications to the specific procedures
which have been illustrated may be practiced within the
scope of the appended claims.





Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date Unavailable
(22) Filed 1989-11-29
(41) Open to Public Inspection 1991-05-29
Examination Requested 1996-10-15
Dead Application 1999-11-29

Abandonment History

Abandonment Date Reason Reinstatement Date
1998-11-30 FAILURE TO PAY APPLICATION MAINTENANCE FEE
1999-05-04 FAILURE TO PAY FINAL FEE

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $0.00 1989-11-29
Registration of a document - section 124 $0.00 1990-04-20
Maintenance Fee - Application - New Act 2 1991-11-29 $100.00 1991-10-18
Maintenance Fee - Application - New Act 3 1992-11-30 $100.00 1992-10-30
Maintenance Fee - Application - New Act 4 1993-11-29 $100.00 1993-10-13
Maintenance Fee - Application - New Act 5 1994-11-29 $150.00 1994-10-14
Maintenance Fee - Application - New Act 6 1995-11-29 $150.00 1995-10-12
Maintenance Fee - Application - New Act 7 1996-11-29 $150.00 1996-10-29
Maintenance Fee - Application - New Act 8 1997-12-01 $150.00 1997-10-24
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
LOYOLA UNIVERSITY OF CHICAGO
Past Owners on Record
BABLER, JAMES H.
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Representative Drawing 1999-07-08 1 1
Claims 1998-09-16 1 23
Cover Page 1994-02-05 1 12
Abstract 1994-02-05 1 10
Claims 1994-02-05 8 151
Description 1994-02-05 23 723
Fees 1996-10-29 1 30
Fees 1995-10-12 1 29
Fees 1994-10-14 1 42
Fees 1993-10-13 1 36
Fees 1992-10-30 1 24
Fees 1991-10-18 1 29